Acciones Leviathan Cannabis Group Inc Toronto S.E.
Acciones
CA61762Y1051
Farmacéuticos
Ventas 2022 | 842 mil 616 mil 565 mil | Ventas 2023 | 35,34 M 25,83 M 23,71 M | Capitalización | 219 M 160 M 147 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -4 M -2,92 M -2,68 M | Resultado Neto 2023 | - 0 0 | VE / Ventas 2022 | 150 x |
Deuda neta 2022 | 8,9 M 6,5 M 5,97 M | Deuda neta 2023 | 3,32 M 2,42 M 2,22 M | VE / Ventas 2023 | 6,28 x |
P/E ratio 2022 |
-23,4
x | P/E ratio 2023 |
-238
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 87,12 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/03/22 |
Director of Finance/CFO | - | 07/03/22 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/03/22 |
Rupalee Mehta
BRD | Director/Board Member | - | 07/03/22 |
Lucas Leone
BRD | Director/Board Member | - | 07/03/22 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+61,53 % | 856 mil M | |
+38,95 % | 631 mil M | |
-3,66 % | 359 mil M | |
+15,06 % | 325 mil M | |
+9,18 % | 297 mil M | |
+5,89 % | 234 mil M | |
+16,53 % | 226 mil M | |
+15,67 % | 177 mil M | |
+2,47 % | 165 mil M |